ProShare Advisors
ACHV icon

ProShare Advisors’s Achieve Life Sciences ACHV Stock Holding History

ProShare Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Buy
+10,192
New +$48.6K ﹤0.01% 1825
2014
Q2 		– Sell
-7
Closed -$175K – 2446
2014
Q1 		$175K Buy
+7
New +$172K ﹤0.01% 2557

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ProShare Advisors's ACHV Position: Q2 2026 in Review

ProShare Advisors opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 10,192 shares worth $66.6K. The stake represents ﹤0.01% of the portfolio and ranks #1825 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in ACHV as recently as Q1 2014.

ProShare Advisors first reported a position in ACHV in Q1 2014 and has held it in 2 quarters since. The position peaked at $175K in Q1 2014. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • ProShare Advisors held 10,192 shares of Achieve Life Sciences worth $66.6K as of Q2 2026.
  • Achieve Life Sciences was a new ProShare Advisors position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1825 holding.
  • ProShare Advisors first reported a position in Achieve Life Sciences in Q1 2014 and has held it in 2 quarters since.
  • ProShare Advisors's Achieve Life Sciences position peaked at $175K in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.